Certified by Founder Lodge
Pureos Bioventures
Switzerland - Pfäffikon, Schwyz
INVESTOR
1 Disclosed Funding Rounds $105,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs an
| Company | Date | Round | Raised |
|---|---|---|---|
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
 Ariceum Therapeutics |
April, 19 ,2023 | Series A | $27,393,000 |
 Adcytherix |
June, 12 ,2024 | Seed | $32,219,580 |
 Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
